Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Skin corneocyte adhesion refers to the mechanisms and molecular structures that maintain the cohesion of corneocytes, which are the terminally differentiated, flattened cells forming the outermost layer of skin—the stratum corneum. This adhesion is crucial for skin barrier integrity, resistance to mechanical stress, and protection against pathogens and water loss. The corneodesmosomes, composed of proteins like Desmoglein-1, Desmocollin-1, and Corneodesmosin, are key structural elements. Disruption can compromise barrier function, leading to skin disorders. Certain bacterial adhesins target components involved in human skin cell adhesion, such as Staphylococcus aureus using ClfB to bind ligands like loricrin and CDSN.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Skin Corneocyte Adhesion (N/A).